Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447))

Conference contribution


Publication Details

Author(s): Duerr P, Schlichtig K, Dörje F, Fromm M
Publisher: SPRINGER
Publishing place: NEW YORK
Publication year: 2019
Conference Proceedings Title: NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
ISSN: 0028-1298
eISSN: 1432-1912


FAU Authors / FAU Editors

Dörje, Frank Prof. Dr.
Lehrstuhl für Pharmazeutische Technologie
Fromm, Martin Prof. Dr.
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie
Schlichtig, Katja
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie


How to cite

APA:
Duerr, P., Schlichtig, K., Dörje, F., & Fromm, M. (2019). Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447)). In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Stuttgart, GERMANY: NEW YORK: SPRINGER.

MLA:
Duerr, P., et al. "Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447))." Proceedings of the 21st Annual Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology (DGPT) / 21st Annual Meeting of the Association-of-the-Clinical-Pharmacology-Germany (VKliPha), Stuttgart, GERMANY NEW YORK: SPRINGER, 2019.

BibTeX: 

Last updated on 2019-10-07 at 10:47